secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-07-31T20:15:35+00:00
Accession:  0001140361-26-030497
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology receives Nasdaq deficiency notice for bid price below $1.00
-----------------------------------------------------------------------------

- Received deficiency letter on July 30, 2026 for failing to meet minimum bid price of $1.00 for 30 consecutive business days.
- Has 180 calendar days, until January 26, 2027, to regain compliance with Nasdaq Listing Rule 5550(a)(2).
- Compliance can be regained if closing bid price is at least $1.00 for 10 consecutive business days during the period.
- Company may consider a reverse stock split to cure the deficiency; no assurance of regaining compliance.
- If not cured by deadline, stock may be delisted; company can appeal a delisting determination to a hearings panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126030497/0001140361-26-030497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126030497/ef20079199_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-030497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer